News

The EU-LIFE community is deeply sad by the passing away of one of its Board of Directors’ member: Michael Wakelam, Director of The Babraham Institute, who died on 1st of April from respiratory complications arising from a suspected Covid-19 infection.

Find out our 2019 highlights in European science policy, Institutional practice and expertise and in EU-LIFE strategy.

The first call of the Visiting Postdoctoral EU-LIFE seminars programme closed in December 2019. 18 excellent candidates were selected to give a talk about their research work throughout the year 2020. Congratulations to all!

The first main representatives meeting took place in Amsterdam at NKI, The Netherlands Cancer Institute, on 21st of February. This work session gave the opportunity to consolidate common ground for the main representatives and to launch strategic steps for the future.

The EU-LIFE community, which spans over 7500 researchers in 14 European countries including our UK partner The Babraham Institute, will continue to join forces with researchers, innovators, policy makers and all relevant actors across the European continent to enable the best science and ensure the transformation of scientific achievements into improvements in peoples’ lives.

With the post-BREXIT situation, the time to re-shape the relationship between the EU and UK has arrived. This doesn’t mean that international collaboration in science and research is any less essential. EU-LIFE, EuroScience and Wellcome have launched the #dealforscience petition to help the research community show how much they want a good deal for science.

The International Institute of Molecular and Cell Biology in Warsaw (IIMCB) has officially joined EU-LIFE as part of the process of expansion of the alliance. The decision was ratified by the EU-LIFE Board of Directors and the IIMCB Director and is effective as of January 1, 2020.

We are looking for a Project and Policy Officer to join EU-LIFE team. This is a great opportunity to work on an international alliance dedicated to the improvement of life sciences research through science policy and sharing practices in research governance.